| P2093 | author name string | Y-M Chen | |
| | D-Y Chen | |
| | J-L Lan | |
| | M-C Wen | |
| | T-Y Hsieh | |
| | W-T Hung | |
| P2860 | cites work | Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 | Q28213628 |
| | The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation | Q28266133 |
| | A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 |
| | Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 |
| | IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways | Q29614839 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis | Q33508917 |
| | Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study | Q33527462 |
| | Th17 cells: effector T cells with inflammatory properties | Q33732092 |
| | Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus | Q33923351 |
| | The classification of glomerulonephritis in systemic lupus erythematosus revisited | Q34293066 |
| | Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. | Q34765324 |
| | IL-17 and the Th17 lineage in systemic lupus erythematosus | Q34807773 |
| | Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 |
| | Th17 and natural Treg cell population dynamics in systemic lupus erythematosus | Q34978528 |
| | Distinct regulation of interleukin-17 in human T helper lymphocytes | Q36571575 |
| | Update on the treatment of lupus nephritis | Q36575376 |
| | T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 |
| | gammadelta T cells: an important source of IL-17. | Q37012968 |
| | Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells | Q37207000 |
| | Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway | Q37292757 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | Th1 and Th17 cells induce proliferative glomerulonephritis | Q37477762 |
| | The Th17 immune response in renal inflammation | Q37726972 |
| | IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus | Q37777456 |
| | IL-17-producing T cells in lupus nephritis | Q37838092 |
| | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | Mast cells express IL-17A in rheumatoid arthritis synovium | Q46151437 |
| | Acute renal dysfunction after cardiac surgery with cardiopulmonary bypass is associated with plasmatic IL6 increase. | Q46172099 |
| | Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis | Q46862865 |
| | Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease | Q49043582 |
| | Cytokine balance in kidney tissue from lupus nephritis patients | Q53655942 |
| | Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. | Q54444518 |
| P433 | issue | 13 | |
| P304 | page(s) | 1385-1396 | |
| P577 | publication date | 2012-08-14 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis | |
| P478 | volume | 21 | |